logo
Graphite electrodes shares in demand; Graphite, HEG soar 15%; here's why

Graphite electrodes shares in demand; Graphite, HEG soar 15%; here's why

Graphite India, HEG share price today
Shares of graphite electrodes companies, Graphite India and HEG, rallied up to 15 per cent on the BSE in Monday's intraday trade. The rise in Graphite India and HEG shares came amid reports of Japan's Resonac planning to close graphite electrode plants in China and Malaysia.
Individually, Graphite India zoomed 15 per cent to ₹558.75, hitting an over three-month high on the BSE. The average trading volume on the counter jumped nearly 10-times today with as many as 7.27 million equity shares, cumulatively, changing hands on the NSE and BSE.
Shares of HEG, meanwhile, surged 11 per cent to ₹544.65 on the back of a three-fold rise in its average trading volume. Around 5.32 million shares, together, changed hands on the NSE and BSE till the time of writing this report.
What's driving the rally in Graphite India, HEG stock prices?
According to reports, Japan's Resonac will quit Chinese and Southeast Asian production of graphite electrodes for steelmakers, scaling back in a bid to improve margins that have been squeezed by an influx of low-priced Chinese parts.
Graphite electrodes are used in electric arc furnace (EAF) based steel mills and is a consumable item for the steel industry. The graphite electrode industry is highly consolidated with the top five major global manufacturers accounting for almost 75 per cent of the high end UHP electrode capacity. The majority of this capacity, however, is currently located in high cost regions like the US, Europe, and Japan.
K K Bangur, Chairman of Graphite India, on May 14, 2025, said that the graphite electrode prices remain under pressure, while raw material costs, particularly petroleum needle coke, have not declined in tandem, leading to an impact on operating margins.
Given the company's diversified export portfolio across multiple geographies, the impact of any US tariffs on the company's financial performance is limited.
That said, the outlook for graphite electrodes remains positive with the medium-term move towards EAF-based production, which supports lower carbon emissions and greater operational flexibility. As of 2023, EAFs accounted for 28 per cent of global steel production, with this projected to increase to 41 per cent by 2030.
In the US, the transition is more advanced with 68 per cent of steel already produced through the EAF route, highlighting the growing move towards cleaner steelmaking technologies. In line with these global sustainability initiatives, approximately 100 million tonnes of new EAF capacity is expected to be added over the next 2 to 3 years.
The focus on substantial decarbonisation measures in developing economies supports the growth of the EAF process compared with the Blast Furnace / Bessimer Oxygen Furnace (BF/BOF) process. Governments around the world are also introducing stringent environmental regulations to reduce pollution. This will further support the growth of the EAF process and along with decarbonization, drive the future demand for graphite electrodes.
The use of the EAF process in the steel industry is not only important for sustainable steel production but is a more cost-effective manufacturing method.
About Graphite India
Graphite India is the largest Indian producer of graphite electrodes and one of the largest globally by total capacity. Its manufacturing capacity of 98,000 tonnes per annum is spread over three plants at Durgapur and Nashik in India and Nurnberg in Germany.
The company, through its subsidiary, has progressively acquired and now owns more than a 60 per cent stake in General Graphene Corporation, a US based company which has developed a breakthrough proprietary technology which would allow it to produce large area, high quality, low cost graphene sheets in industrial applications in scaled up commercial volumes.
Graphite India has also acquired a 31 per cent stake in Godi India. This investment is part of its strategy to diversify into advanced chemistry battery technologies for the development of electric vehicle (EV) and energy storage battery cells.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Reliance Power Soars 11%, Up 174% In A Year – Will The Rally Sustain?
Reliance Power Soars 11%, Up 174% In A Year – Will The Rally Sustain?

News18

time22 minutes ago

  • News18

Reliance Power Soars 11%, Up 174% In A Year – Will The Rally Sustain?

Last Updated: Reliance Power Share Price: Shares of Reliance Power surged on Tuesday, hitting a fresh 10-year high RPower Share Price: Shares of Reliance Power surged on Tuesday, hitting a fresh 10-year high of Rs 71.35, as they rallied 11 per cent on the BSE in intra-day trade amid heavy volumes. At this price, the stock has soared nearly 68 per cent so far in 2025 and 174 per cent over the past year. In June alone, it has gained more than 20 per cent following a 45 per cent surge in May. The recent momentum in this power stock has been driven by its robust Q4 earnings and a positive outlook. For the March 2025 quarter (Q4FY25), Reliance Power reported a consolidated profit of Rs 125.57 crore, reversing a loss of Rs 397.56 crore in the same period last year (Q4FY24). However, consolidated revenue from operations dipped slightly by nearly 1 per cent to Rs 1,978.01 crore from Rs 1,996.65 crore a year earlier. Meanwhile, Reliance Power's subsidiary, Reliance NU Energies Private Limited, on May 28 received a letter of award (LOA) from SJVN Limited—a Navratna Central Public Sector Enterprise—for a 350 MW inter-state transmission system (ISTS)-connected solar power project, along with a 175 MW/700 MWh battery energy storage system (BESS). Reliance Power growth opportunities According to the National Electricity Plan, India plans to add around 80 gigawatts (GW) of new coal-based thermal power capacity by 2031–32 to meet growing electricity demand. In its FY24 annual report, Reliance Power highlighted that this renewed focus presents growth prospects for thermal power players. Rising electrification, higher per-capita power consumption, and the adoption of electric vehicles (EVs) are expected to drive demand. India also aims to achieve 500 GW of non-fossil capacity by 2030 as part of its energy transition. 'In the near term, prices may continue to rise, but given the overbought conditions, buying on dips would be ideal. Rs 56-57 appears to be strong support, while Rs 72 is seen as resistance," Bhosale said. Further, Riyank Arora, Technical Analyst at Mehta Equities, observed that Reliance Power share price is showing signs of profit-booking after the recent rally, with major resistance at Rs 65. 'Reliance Power has seen a significant run-up, and the current pause suggests a short-term consolidation or mild correction. If it fails to break above Rs 65, we may see selling pressure pushing it back towards the Rs 58–59 support zone. While momentum remains positive, traders should be cautious near resistance. Fresh entry is only recommended on a decisive breakout above Rs 65 with strong volume," Arora explained. Disclaimer:Disclaimer: The views and investment tips by experts in this report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.

Glenmark Pharma rises 2% as company to launch blood cancer treatment drug
Glenmark Pharma rises 2% as company to launch blood cancer treatment drug

Business Standard

time23 minutes ago

  • Business Standard

Glenmark Pharma rises 2% as company to launch blood cancer treatment drug

Glenmark Pharma share price rose 1.7 per cent in trade on Tuesday, June 10, 2025, logging an intraday high at ₹1,626.6 per share on BSE. At 10:30 AM, Glenmark Pharma shares were trading 1.56 per cent higher at ₹1,623.35 per share on the BSE. In comparison, the BSE Sensex was up 0.05 per cent at 82,482.52. The company's market capitalisation stood at ₹45,811.07 crore. Its 52-week high was at ₹1,830.05 per share and 52-week low was at ₹1,176 per share. In the past one year, Glenmark shares have gained 33 per cent as compared to Sensex's rise of around 8 per cent. What is boosting rally in Glenmark Pharma shares? The stock gained after the company announced the upcoming launch of zanubrutinib, under the brand name Brukinsa in India. Brukinsa, developed by global oncology company BeOne Medicines (formerly BeiGene), is an orally available Bruton's tyrosine kinase (BTK) inhibitor designed to treat multiple types of B-cell blood cancers. It is the first and only BTK inhibitor approved in India for five types of B-cell malignancies. According to the filing, Brukinsa has already been approved in more than 70 countries, with clinical efficacy demonstrated through trials such as ALPINE, ASPEN and SEQUOIA. Its entry into the Indian market addresses a critical need for new and effective blood cancer treatments. The drug offers a unique pharmacological profile with high response rates and durable disease control across multiple B-cell malignancies. It allows a flexible dosing schedule—once or twice daily—tailored to patient needs. In the ALPINE trial for relapsed or refractory chronic lymphocytic leukaemia (CLL), Brukinsa showed a lower incidence of serious cardiac side effects compared to ibrutinib, a widely used targeted therapy. Fewer patients discontinued Brukinsa due to heart-related complications. About Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 11 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries. About BeOne Medicines BeOne Medicines, formerly known as BeiGene, is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide.

RITES bags LoA from Guyana's Public Works Ministry for $2.9 million project
RITES bags LoA from Guyana's Public Works Ministry for $2.9 million project

Business Standard

time25 minutes ago

  • Business Standard

RITES bags LoA from Guyana's Public Works Ministry for $2.9 million project

RITES said that it has received letter of acceptance (LOA) for a coastal road project from the Ministry of Public Works, the Co-operative Republic of Guyana worth $2.908 million. Under the contract, RITES will provide construction supervision for the extension of the East Bank-East Coast Road Project Phase 2 (Eccles to Providence), which also includes additional work for an existing assignment. The project is slated for completion within 18 months of construction supervision, followed by a 12-month defects liability period. RITES, a Miniratna (Category-I) Schedule 'A' public sector enterprise, is a leading player in the transport consultancy and engineering sector in India, having diversified services and geographical reach. As of 31 March 2025, the Government of India held 72.20% stake in the company. The company's consolidated net profit rose 5.24% to Rs 132.71 crore despite a 4.32% decline in revenue to Rs 615.43 crore in Q4 FY25 as compared with Q4 FY24. The scrip rose 0.94% to currently trade at Rs 305.10 on the BSE.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store